What is Diality?
Diality is a privately held medical device company dedicated to developing a versatile hemodialysis machine designed for use in diverse settings, including homes, nursing facilities, hospitals, and specialized dialysis centers. The company's mission is to empower patients and healthcare providers with greater control over kidney disease management. By focusing on flexible and personalized dialysis treatments, Diality aims to significantly improve the quality of life for patients suffering from kidney disease, offering physicians enhanced prescribing flexibility irrespective of the care environment.
How much funding has Diality raised?
Diality has raised a total of $74.8M across 4 funding rounds:
Series A
$10M
Debt
$350K
Series B
$36.5M
Other Financing Round
$28M
Series A (2019): $10M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Series B (2022): $36.5M, investors not publicly disclosed
Other Financing Round (2023): $28M, investors not publicly disclosed
Key Investors in Diality
PPP
Public-Private Partnership
What's next for Diality?
The recent major strategic investment signals a pivotal growth phase for Diality. This capital infusion is expected to accelerate the company's product development pipeline, scale manufacturing capabilities, and expand its market reach. With a clear focus on innovation and patient-centric solutions, Diality is strategically positioned to address critical unmet needs in the kidney care sector. Future endeavors will likely involve further clinical validation, regulatory approvals, and the establishment of key partnerships to ensure widespread adoption of their advanced hemodialysis technology.
See full Diality company page
